Genetic footprinting of the HIV co-receptor CCR5: delineation of surface expression and viral entry determinants

被引:5
|
作者
Quinonez, R
Sinha, I
Singh, IR
Sutton, RE [1 ]
机构
[1] Baylor Coll Med, Ctr Cell & Gene Therapy, Dept Mol Virol & Microbiol, Houston, TX 77030 USA
[2] Columbia Univ Coll Phys & Surg, Dept Pathol, New York, NY 10032 USA
关键词
D O I
10.1016/S0042-6822(02)00032-6
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Human immunodeficiency virus type 1 (HIV-1) utilizes CD4 as a primary receptor for viral entry and any of several 7-transmembrane chemokine receptors, including CCR5, as a co-receptor. Previous studies have demonstrated that multiple extracellular domains (ECDs) of CCR5 contribute to co-receptor function; here we applied genetic footprinting to CCR5 to confirm and extend those investigations. In genetic footprinting, a duplex oligonucleotide is inserted into the DNA sequence of interest by use of either a bacterial transposase or retroviral integrase. Here, CCR5 mutants were analyzed in bulk for their ability to be expressed on the recipient cell surface and to mediate viral entry of R5 HIV isolates. Most of the approximately 150 CCR5 mutants were not expressed on the cell surface. Of those remaining, 8 were specifically reduced or absent after macrophage (M)-tropic HIV infection, confirming a critical role of ECDs three (extracellular loop 2 or ECL2) and possibly four (ECL3) in viral entry. Mutational and functional analyses of ECD4 (ECL3) suggest it is under severe topological constraint for CCR5 surface expression and are consistent with it contributing to co-receptor function. (C) 2003 Elsevier Science (USA). All rights reserved.
引用
收藏
页码:98 / 115
页数:18
相关论文
共 50 条
  • [1] Expression of the CCR5 HIV co-receptor in women with genital schistosomiasis
    Kleppa, E.
    Ramsuran, V.
    Zulu, S.
    Karlsen, G. H.
    Ndhlovu, P.
    Lillebo, K.
    Holmen, S. D.
    Onsrud, M.
    Gundersen, S. G.
    Taylor, M.
    Kjetland, E. F.
    Ndung'u, T.
    [J]. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2014, 21 : 60 - 60
  • [3] Endocytosis and recycling of the HIV co-receptor CCR5
    Marsh, M
    Signoret, N
    Pelchen-Matthews, A
    [J]. MOLECULAR BIOLOGY OF THE CELL, 2000, 11 : 141A - 141A
  • [4] The HIV co-receptor CCR5 regulates osteoclast function
    Ji-Won Lee
    Akiyoshi Hoshino
    Kazuki Inoue
    Takashi Saitou
    Shunsuke Uehara
    Yasuhiro Kobayashi
    Satoshi Ueha
    Kouji Matsushima
    Akira Yamaguchi
    Yuuki Imai
    Tadahiro Iimura
    [J]. Nature Communications, 8
  • [5] Crystal structure of CCR5 co-receptor of HIV elucidated
    Thorne, Jessica
    [J]. FUTURE MEDICINAL CHEMISTRY, 2013, 5 (17) : 2017 - 2017
  • [6] The HIV co-receptor CCR5 regulates osteoclast function
    Lee, Ji-Won
    Hoshino, Akiyoshi
    Inoue, Kazuki
    Saitou, Takashi
    Uehara, Shunsuke
    Kobayashi, Yasuhiro
    Ueha, Satoshi
    Matsushima, Kouji
    Yamaguchi, Akira
    Imai, Yuuki
    Iimura, Tadahiro
    [J]. NATURE COMMUNICATIONS, 2017, 8
  • [7] Inhibition of HIV-1 infection by PEHMB involves perturbation of the viral co-receptor CCR5
    Qian, Jin
    Thakkar, Nina
    Schlipf, Lori
    Ferguson, Mary L.
    Miller, Shendra
    Kish-Catalone, Tina
    Wigdahl, Brian
    Labib, Mohamed
    Rando, Robert
    Krebs, Fred C.
    [J]. JOURNAL OF NEUROVIROLOGY, 2006, 12 : 68 - 68
  • [8] HIV-1 chemokine co-receptor CCR5 is expressed on the surface of human spermatozoa
    Muciaccia, B
    Padula, F
    Gandini, L
    Lenzi, A
    Stefanini, M
    [J]. AIDS, 2005, 19 (13) : 1424 - 1426
  • [9] Viral MIPα homologous with human MIP-1α acts on HIV co-receptor CCR5
    Sun, HX
    Feng, LX
    Li, YC
    He, WF
    [J]. CHINESE SCIENCE BULLETIN, 2001, 46 (15): : 1308 - 1312
  • [10] Viral MIPα homologous with human MIP-1α acts on HIV co-receptor CCR5
    SUN Hanxiao
    2. Department of Pathology
    [J]. Science Bulletin, 2001, (15) : 1308 - 1312